Canlyniadau Chwilio - De Cock, Diederik

Smartphones for musculoskeletal research – hype or hope? Lessons from a decennium of mHealth studies gan Beukenhorst, Anna L., Druce, Katie L., De Cock, Diederik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs) gan De Cock, Diederik, Myasoedova, Elena, Aletaha, Daniel, Studenic, Paul

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis gan Doumen, Michaël, De Cock, Diederik, Pazmino, Sofia, Bertrand, Delphine, Joly, Johan, Westhovens, René, Verschueren, Patrick

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Patients’ experiences with intensive combination treatment strategies for early rheumatoid arthritis: a longitudinal qualitative study embedded in the carera trial gan Meyfroidt, Sabrina, Van der Elst, Kristien, De Cock, Diederik, Joly, Johan, Westhovens, René, Hulscher, Marlies, Verschueren, Patrick

Cael y testun llawn Cael y testun llawn

An exploration of the relative importance of barriers hindering intensive combination treatment strategies in early rheumatoid arthritis gan Meyfroidt, Sabrina, Hulscher, Marlies, De Cock, Diederik, Van der Elst, Kristien, Joly, Johan, Westhovens, René, Verschueren, Patrick

Cael y testun llawn Cael y testun llawn

The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologist gan De Cock, Diederik, Van der Elst, Kristien, Stouten, Veerle, Peerboom, Donna, Joly, Johan, Westhovens, Rene, Verschueren, Patrick

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the... gan Pazmino, Sofia, Boonen, Annelies, De Cock, Diederik, Stouten, Veerle, Joly, Johan, Bertrand, Delphine, Westhovens, René, Verschueren, Patrick

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Soc... gan Silva-Fernández, Lucía, De Cock, Diederik, Lunt, Mark, Low, Audrey S, Watson, Kath D, Symmons, Deborah P M, Hyrich, Kimme L

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis gan Kearsley-Fleet, Lianne, Davies, Rebecca, De Cock, Diederik, Watson, Kath D, Lunt, Mark, Buch, Maya H, Isaacs, John D, Hyrich, Kimme L

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups gan Doumen, Michaël, Westhovens, René, Pazmino, Sofia, Bertrand, Delphine, Stouten, Veerle, Neys, Claudia, Creten, Nelly, Van Laeken, Els, Verschueren, Patrick, De Cock, Diederik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment gan Van der Elst, Kristien, Verschueren, Patrick, De Cock, Diederik, De Groef, An, Stouten, Veerle, Pazmino, Sofia, Vriezekolk, Johanna, Joly, Johan, Moons, Philip, Westhovens, René

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra gan Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study gan Stouten, Veerle, Pazmino, Sofia, Verschueren, P, Mamouris, Pavlos, Westhovens, René, de Vlam, Kurt, Bertrand, Delphine, Van der Elst, Kristien, Vaes, Bert, De Cock, Diederik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data gan Davies, Rebecca, De Cock, Diederik, Kearsley-Fleet, Lianne, Southwood, Taunton, Baildam, Eileen, Beresford, Michael W, Foster, Helen E, Thomson, Wendy, Ramanan, Athimalaipet V, Hyrich, Kimme L

Cael y testun llawn Cael y testun llawn Cael y testun llawn

‘More than just chitchat’: a qualitative study concerning the need and potential format of a peer mentor programme for patients with early rheumatoid arthritis gan Van der Elst, Kristien, De Cock, Diederik, Bangels, Lore, Peerlings, Lianne, Doumen, Michael, Bertrand, Delphine, De Caluwé, Lies, Langers, Ilse, Stouten, Veerle, Westhovens, René, Verschueren, P

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis gan Kearsley-Fleet, Lianne, Vicente González, Laura, Steinke, Douglas, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Beresford, Michael W, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom gan Kearsley-Fleet, Lianne, Sampath, Sunil, McCann, Liza J, Baildam, Eileen, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The perception of stakeholders on the applicability of nurse-led clinics in the management of rheumatoid arthritis gan Doumen, Michaël, Westhovens, René, Vandeputte, Maryline, Van Melder, Rani, Van der Elst, Kristien, Pazmino, Sofia, Bertrand, Delphine, Stouten, Veerle, Van Laeken, Els, Creten, Nelly, Neys, Claudia, Verschueren, Patrick, De Cock, Diederik

Cael y testun llawn Cael y testun llawn Cael y testun llawn

EULAR recommendations for a core data set for pregnancy registries in rheumatology gan Meissner, Yvette, Fischer-Betz, Rebecca, Andreoli, Laura, Costedoat-Chalumeau, Nathalie, De Cock, Diederik, Dolhain, Radboud J E M, Forger, Frauke, Goll, Doreen, Molto, Anna, Nelson-Piercy, Catherine, Özdemir, Rebecca, Raio, Luigi, Rodríguez-García, Sebastian Cruz, Sciascia, Savino, Wallenius, Marianne, Zbinden, Astrid, Zink, Angela, Strangfeld, Anja

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the random... gan Verschueren, Patrick, De Cock, Diederik, Corluy, Luk, Joos, Rik, Langenaken, Christine, Taelman, Veerle, Raeman, Frank, Ravelingien, Isabelle, Vandevyvere, Klaas, Lenaerts, Jan, Geens, Elke, Geusens, Piet, Vanhoof, Johan, Durnez, Anne, Remans, Jan, Vander Cruyssen, Bert, Van Essche, Els, Sileghem, An, De Brabanter, Griet, Joly, Johan, Van der Elst, Kristien, Meyfroidt, Sabrina, Westhovens, Rene

Cael y testun llawn Cael y testun llawn Cael y testun llawn